搜索临床试验以:TKI-258
总计556个结果
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Guangdong Association of Clinical Trials未知
-
Tongji UniversitySun Yat-sen University; Peking Union Medical College Hospital; RenJi Hospital; Guangdong Provincial... 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...完全的Human Parainfluenza Virus 2美国
-
Erasmus Medical Center招聘中
-
The Fourth Affiliated Hospital of Zhejiang University...完全的
-
Thomas Jefferson UniversityRutgers University; West Chester University of Pennsylvania主动,不招人
-
AbbVie撤销
-
M.D. Anderson Cancer Center完全的
-
Centro de Investigacion SanitariaUniversity of Helsinki; International Diabetes Federation完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Novartis Pharmaceuticals完全的
-
Hellenic Oncology Research GroupUniversity Hospital of Crete终止
-
Memorial Sloan Kettering Cancer Center主动,不招人甲状腺癌,滤泡性 | 甲状腺癌 | 乳头状甲状腺癌 | 低分化甲状腺癌 | 滤泡性甲状腺癌 | Hurthle 细胞瘤 | Hurthle 细胞甲状腺瘤美国
-
Incyte Corporation完全的
-
University of MichiganUniversity of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI); Emory University完全的
-
University of Florida完全的
-
Shanghai Pulmonary Hospital, Shanghai, China未知非小细胞肺癌 | 表皮生长因子受体基因突变
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Summit TherapeuticsDepartment of Health and Human Services终止
-
Tianjin Medical University Cancer Institute and...尚未招聘TKI 治疗取得进展的 HER2+ 晚期乳腺癌患者
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
Shanghai Cancer Hospital, China未知肺癌IV期,EGFR突变,TKI,PD-L1,SBRT中国
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)撤销胃泌素瘤 | 胰高血糖素瘤 | 胰岛素瘤 | 胰腺多肽瘤 | 复发性胰岛细胞癌 | 生长抑素瘤